Oral birch pollen immunotherapy with apples: Results of a phase II clinical pilot study

BACKGROUND: Seventy percent of patients suffering from birch pollen allergy (BPA) develop a pollen‐related food allergy (prFA), especially to apples, due to a clinically relevant cross‐reactivity between the major allergen in birch Bet v 1 and Mal d 1 in apples. Therefore allergen‐specific immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nothegger, Bettina, Reider, Norbert, Covaciu, Claudia E., Cova, Valentina, Ahammer, Linda, Eidelpes, Reiner, Unterhauser, Jana, Platzgummer, Stefan, Raffeiner, Elisabeth, Tollinger, Martin, Letschka, Thomas, Eisendle, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127540/
https://www.ncbi.nlm.nih.gov/pubmed/33621436
http://dx.doi.org/10.1002/iid3.410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127540/
https://www.ncbi.nlm.nih.gov/pubmed/33621436
http://dx.doi.org/10.1002/iid3.410

Ejemplares similares